Valmet will supply a complete tissue line, including full automation package, to WEPA’s mill in Bridgend, the United Kingdom. The investment is a strategic step for the company to strengthen its presence in the United Kingdom.
The order is included in Valmet’s orders received of the third quarter 2020. The value of the order will not be disclosed.
“Our willingness to invest in state-of-the-art technology is an important part of our future-oriented Group strategy and the United Kingdom remains an important growth market for us in Europe. We are convinced that with Valmet we have the right partner at our side to successfully implement this project,” says Martin Krengel, CEO of the WEPA Group.
“We are excited to collaborate with WEPA and to be selected as partner for their expansion in the United Kingdom. We are convinced that the new Valmet Advantage DCT line will provide the best performance and tissue quality to meet WEPA’s high expectations for this project,” says Jan Erikson, Vice President Sales, Tissue Mills business unit, Paper business line, Valmet.
TAPPI
http://www.tappi.org/